RE: IPO on Monday?26 Jul 2022 16:09
Just to remind you guys what Simon from IC said bak on 6th June;
This implies the shares are trading on a 33 per cent discount, a valuation that completely ignores the potential for a bumper gain to be realised from the forthcoming Nasdaq IPO of Innovative Eyewear (US: LUCY), the US operating subsidiary of Lucyd, the first company to deliver prescription glasses with Bluetooth technology.
At the mid-point of the $5.50 to $7.50 per share valuation range, Tek’s 5.1mn shares in Innovative Eyewear are worth $33.2mn (as per Nasdaq filings on 27 May 2022 while I was on annual leave), including the conversion of a $1.2mn loan note into 0.19mn shares. In Tek’s 2021 annual accounts, the equity stake was held in the books for only $17.3mn. Even at the bottom end of the IPO valuation range, it is worth 56 per cent more than Tek’s carrying value, adding 5.5p a share to lift Tek’s proforma NAV per share to 44.5p. Buy.
Given the new price range of $7.50 to $9.50 it makes the valuation price gap from TEK's accounts even greater. Roll on Monday for the IPO.
GLA